Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China

The Study of Early Detection, Disease Course and Prognosis of Pulmonary Thromboembolism in Chronic Pulmonary Hypertension

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03185377

Enrollment

1708

Registered

2017-06-14

Start date

2017-03-15

Completion date

2020-12-31

Last updated

2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, PTE - Pulmonary Thromboembolism

Brief summary

Chronic obstructive pulmonary disease (COPD) is closely related to venous thromboembolism (VTE). But it is difficult to identify VTE in COPD patients in clinical practice. Therefore, the prevalence data of PTE in COPD is limited. Pulmonary thromboembolism (PTE) is an important factor effecting patients outcomes, but existing researches only have short follow-up time less than 1 year. This study aim to develop an early detection system of PTE in COPD and explore the disease course and prognosis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbation

Exclusion criteria

* Stable COPD patients * COPD hospitalized for definite causes other than pulmonary thromboembolism * Patients with malignant tumor * Patients with contraindications for CT pulmonary angiography * Psychopath

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality	3 years	mortality in %

Secondary

Measure	Time frame	Description
COPD exacerbations	3 years	Total times
venous thromboembolism recurrence	3 years	total times
major bleeding	3 years	total times

Countries

China

Contacts

Primary ContactYuanhua Yang, MD

yyh1031@sina.com13911773607

Outcome results